BIOTIE THERAPIES CORP.

Profile

Company Names

BIOTIE THERAPIES CORP.

Addresses

JOUKAHAISENKATU 6, TURKU, H9 FI-20520

TYKISTOKATU 6, FI-20520, TURKU, H9 FI-20520

Phone Numbers

358-2-274-8900

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

FINLAND

Total Amount Raised:

$149,808,176.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2015-05-28 
$6,058,176.00 
$16,344,000.00 
$10,285,824.00 
Debt 
1
2013-06-11 
$143,750,000.00 
$143,750,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DON 
MATTHEW 
BAILEY 
DIRECTOR
BIOTIE THERAPIES CORP.
STEPHEN 
 
BANDAK 
EXECUTIVE OFFICER
BIOTIE THERAPIES CORP.
WILLIAM 
 
BURNS 
DIRECTOR
BIOTIE THERAPIES CORP.   |  ENCORE VISION, INC.   |  NPXE LTD   |  MESOBLAST LTD
WILLIAMS 
 
BURNS 
DIRECTOR
BIOTIE THERAPIES CORP.
DAVID 
 
COOK 
EXECUTIVE OFFICER
PANTHERYX, INC.   |  BIOTIE THERAPIES CORP.   |  SERES HEALTH, INC.   |  ALTO REIT, LLC   |  DEGREESIGHT INC   |  MORGAN HILLS CAPITAL, LLC   |  MORGAN STANLEY NEXT LEVEL FUND, L.P.   |  SHAED, INC.
PETER 
 
FELLNER 
DIRECTOR
BIOTIE THERAPIES CORP.
MERJA 
 
KARHAPAA 
DIRECTOR
BIOTIE THERAPIES CORP.
BERND 
 
KASTLER 
DIRECTOR
BIOTIE THERAPIES CORP.
ISMAIL 
 
KOLA 
DIRECTOR
ATHERSYS, INC / NEW   |  BIOTIE THERAPIES CORP.   |  HEMANEXT INC.
GUIDO 
 
MAGNI 
DIRECTOR
BIOTIE THERAPIES CORP.   |  GENSIGHT BIOLOGICS S.A.   |  TARVEDA THERAPEUTICS, INC.
IAN 
 
MASSEY 
EXECUTIVE OFFICER
BIOTIE THERAPIES CORP.   |  DELOS PHARMACEUTICALS, INC.
MEDHI 
 
PABORJI 
EXECUTIVE OFFICER
BIOTIE THERAPIES CORP.
MAHENDRA 
G 
SHAH 
DIRECTOR
BIOTIE THERAPIES CORP.
TIMO 
 
VEROMAA 
EXECUTIVE OFFICER
BIOTIE THERAPIES CORP.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-06-02
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Debt 
2015-05-28 
2013-06-26
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#